Interdisciplinary and Family Intervention to Prevent Type 2 Diabetes (CARE-in-DEEP)
Primary Purpose
Prediabetes
Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Family and interdisciplinary approach
individual approach
Sponsored by
About this trial
This is an interventional prevention trial for Prediabetes
Eligibility Criteria
Inclusion Criteria:
- Patients with prediabetes (Fasting glucose 100-125mg/dl and/or 2h post OGTT glucose 140-199mg/dl)
- Family of patients with prediabetes (in case of the patients that are randomized to FAMILY APPROACH)
- Signing of the inform consent
Exclusion Criteria:
- Type 2 diabetes
- Pregnancy
- Liver disease
- Renal disease
Sites / Locations
- Universidad de Guanajuato
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Family and interdisciplinary approach
individual approach
Arm Description
Family and interdisciplinary approach: Patients in this group will receive a Family and interdisciplinary approach that includes nutritional, physical activity and psychological counseling + metformin 850mg twice at day for 12 months
individual approach: Patients in this group will receive individual approach that includes nutritional and physical activity counseling + metformin 850mg twice at day for 12 months
Outcomes
Primary Outcome Measures
Individual Insulin Resistance and Insulin Secretion
Whole body insulin sensitivity as determined by the Matsuda Index was calculated using the following formula: 10,000 divided by the square root of (FPI* FPG) * (xGPC* xIPC) Where FPI is fasting plasma insulin expressed as uU/ml, FPG is fasting plasma glucose expressed as mg/dL, xGPC is mean plasma glucose concentration after the load and xIPC is the mean insulin concentration after the load. Values calculated on samples taken at 0, 30, 60, 90 and 120 minutes of a 2 hour OGTT. Values typically range from 0 to 12 units with higher scores indicating better insulin sensitivity (better result). A value of 2.5 or less is indicative of low insulin sensitivity (worst result).
Individual Insulin Resistance and Insulin Secretion
Whole body insulin sensitivity as determined by the Matsuda Index was calculated using the following formula: 10,000 divided by the square root of (FPI* FPG) * (xGPC* xIPC) Where FPI is fasting plasma insulin expressed as uU/ml, FPG is fasting plasma glucose expressed as mg/dL, xGPC is mean plasma glucose concentration after the load and xIPC is the mean insulin concentration after the load. Values calculated on samples taken at 0, 30, 60, 90 and 120 minutes of a 2 hour OGTT. Values typically range from 0 to 12 units with higher values indicating better insulin sensitivity (better result, the higher the value the better the result of this variable). A value of 2.5 or less is indicative of low insulin sensitivity (worst result).
Secondary Outcome Measures
Family Insulin Resistance and Insulin Secretion (Matsuda Index Measured in the Relatives of the Patients)
Whole body insulin sensitivity as determined by the Matsuda Index as calculated using the following formula: 10,000 divided by the square root of (FPI* FPG) * (xGPC* xIPC) Where FPI is fasting plasma insulin expressed as uU/ml, FPG is fasting plasma glucose expressed as mg/dL, xGPC is mean plasma glucose concentration after the load and xIPC is the mean insulin concentration after the load. Values calculated on samples taken at 0, 30, 60, 90 and 120 minutes of a 2 hour OGTT. Values typically range from 0 to 12 units with higher scores indicating better insulin sensitivity (the higher the value the better the result). A value of 2.5 or less is indicative of low insulin sensitivity (worst result).
Weight
Weight in the relatives of the patients
2h OGTT Glucose
Measurement of 2h post OGTT glucose
Full Information
NCT ID
NCT02635646
First Posted
December 15, 2015
Last Updated
June 3, 2019
Sponsor
Universidad de Guanajuato
Collaborators
University of Texas, National Council of Science and Technology, Mexico
1. Study Identification
Unique Protocol Identification Number
NCT02635646
Brief Title
Interdisciplinary and Family Intervention to Prevent Type 2 Diabetes
Acronym
CARE-in-DEEP
Official Title
Efficacy of a Family and Interdisciplinary Intervention to Prevent Diabetes, and Effect on Family Profiles of Insulin Secretion and Insulin Resistance in Patients With Prediabetes
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
October 2015 (undefined)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
February 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad de Guanajuato
Collaborators
University of Texas, National Council of Science and Technology, Mexico
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of the study is to evaluate the effect of a family and interdisciplinary approach on individual and family insulin resistance and insulin secretion in patients with prediabetes.
Detailed Description
This a randomized clinical trial designed to evaluate the efficacy of the following treatments:
Family and interdisciplinary approach that includes nutritional, physical activity and psychological counseling + metformin 850mg twice at day for 12 months
Individual approach that includes nutritional and physical activity counseling + metformin 850mg twice at day for 12 months
To improve individual and family insulin resistance and insulin secretion in patients with prediabetes.
Patients will have a follow-up visit every month in the Metabolic Research Laboratory at the University of Guanajuato, Mexico, and will have a fasting measurement of lipids, glucose and insulin every 3 months, as well as 2h oral glucose tolerance test (OGTT) at basal, 6 and 12 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prediabetes
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
122 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Family and interdisciplinary approach
Arm Type
Experimental
Arm Description
Family and interdisciplinary approach: Patients in this group will receive a Family and interdisciplinary approach that includes nutritional, physical activity and psychological counseling + metformin 850mg twice at day for 12 months
Arm Title
individual approach
Arm Type
Active Comparator
Arm Description
individual approach: Patients in this group will receive individual approach that includes nutritional and physical activity counseling + metformin 850mg twice at day for 12 months
Intervention Type
Other
Intervention Name(s)
Family and interdisciplinary approach
Intervention Description
Family and interdisciplinary approach that includes:
nutritional counseling,
physical activity counseling,
psychological counseling,
metformin 850mg twice at day for 12 months All this with the purpose to improve insulin resistance and insulin secretion in patients with prediabetes. Patients must attend a monthly session together with his family where they will receive the nutritional, physical activity and psychological counseling.
Intervention Type
Other
Intervention Name(s)
individual approach
Intervention Description
individual approach that includes:
nutritional and physical activity counseling in individual appointments,
metformin 850mg twice at day for 12 months, All this with the purpose to improve insulin resistance and insulin secretion. The patients must attend a monthly follow-up individually.
Primary Outcome Measure Information:
Title
Individual Insulin Resistance and Insulin Secretion
Description
Whole body insulin sensitivity as determined by the Matsuda Index was calculated using the following formula: 10,000 divided by the square root of (FPI* FPG) * (xGPC* xIPC) Where FPI is fasting plasma insulin expressed as uU/ml, FPG is fasting plasma glucose expressed as mg/dL, xGPC is mean plasma glucose concentration after the load and xIPC is the mean insulin concentration after the load. Values calculated on samples taken at 0, 30, 60, 90 and 120 minutes of a 2 hour OGTT. Values typically range from 0 to 12 units with higher scores indicating better insulin sensitivity (better result). A value of 2.5 or less is indicative of low insulin sensitivity (worst result).
Time Frame
6 months
Title
Individual Insulin Resistance and Insulin Secretion
Description
Whole body insulin sensitivity as determined by the Matsuda Index was calculated using the following formula: 10,000 divided by the square root of (FPI* FPG) * (xGPC* xIPC) Where FPI is fasting plasma insulin expressed as uU/ml, FPG is fasting plasma glucose expressed as mg/dL, xGPC is mean plasma glucose concentration after the load and xIPC is the mean insulin concentration after the load. Values calculated on samples taken at 0, 30, 60, 90 and 120 minutes of a 2 hour OGTT. Values typically range from 0 to 12 units with higher values indicating better insulin sensitivity (better result, the higher the value the better the result of this variable). A value of 2.5 or less is indicative of low insulin sensitivity (worst result).
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Family Insulin Resistance and Insulin Secretion (Matsuda Index Measured in the Relatives of the Patients)
Description
Whole body insulin sensitivity as determined by the Matsuda Index as calculated using the following formula: 10,000 divided by the square root of (FPI* FPG) * (xGPC* xIPC) Where FPI is fasting plasma insulin expressed as uU/ml, FPG is fasting plasma glucose expressed as mg/dL, xGPC is mean plasma glucose concentration after the load and xIPC is the mean insulin concentration after the load. Values calculated on samples taken at 0, 30, 60, 90 and 120 minutes of a 2 hour OGTT. Values typically range from 0 to 12 units with higher scores indicating better insulin sensitivity (the higher the value the better the result). A value of 2.5 or less is indicative of low insulin sensitivity (worst result).
Time Frame
12 months
Title
Weight
Description
Weight in the relatives of the patients
Time Frame
12 months
Title
2h OGTT Glucose
Description
Measurement of 2h post OGTT glucose
Time Frame
6 and 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients with prediabetes (Fasting glucose 100-125mg/dl and/or 2h post OGTT glucose 140-199mg/dl)
Family of patients with prediabetes (in case of the patients that are randomized to FAMILY APPROACH)
Signing of the inform consent
Exclusion Criteria:
Type 2 diabetes
Pregnancy
Liver disease
Renal disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rodolfo Guardado, Dr
Organizational Affiliation
Universidad de Guanajuato
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universidad de Guanajuato
City
León
State/Province
Guanajuato
ZIP/Postal Code
37670
Country
Mexico
12. IPD Sharing Statement
Learn more about this trial
Interdisciplinary and Family Intervention to Prevent Type 2 Diabetes
We'll reach out to this number within 24 hrs